20 articles
A large cohort study finds HMOs have age-dependent, structure-specific effects on infant gut bacteria that persist to 13 months.
Human milk oligosaccharides shape beneficial gut bacteria in infants, providing lifelong protection against infections and chronic diseases.
A fetal enzyme floods newborns with hyocholic acids that train immune tolerance and shape a healthy gut microbiome—then disappear by adulthood.
Comprehensive review reveals how infant gut bacteria development in first 1000 days determines chronic disease risk throughout life.
Study reveals how beneficial bacteria travel from gut to ovaries, improving reproductive function and delaying aging in laying hens.
New research reveals distinct patterns of intestinal microbiome development in mice, with implications for understanding human infant gut health.
Multi-omics study reveals how specific gut microbes produce acetate to protect liver function and prevent metabolic disorders in dairy cows.
A 51-calf field trial reveals how the feed additive 3-NOP slashes methane by 62% but causes hydrogen buildup that limits productivity gains.
New research reveals how prebiotic inulin reprograms intestinal cells by creating low-oxygen conditions that activate growth signals.
Study reveals how heat stress suppresses lactation by altering gut microbiome and disrupting organ communication pathways.
Scientists discover how different gut bacteria make opposing immune compounds that either activate or block the same immune cells.
Researchers identify Limousia bacteria with unique molecular machinery for degrading intestinal mucus, revealing new microbe-host interactions.
Vaginal microbiota applied to C-section newborns restores a key brain-signaling molecule on skin, improving early neurodevelopment.
Comprehensive review reveals how bacterial and fungal overgrowth in the small intestine triggers systemic inflammation and metabolic dysfunction.
New research shows how beneficial gut bacteria process plant sugars, revealing pathways that could optimize digestive health.
Mother's gut bacteria during pregnancy programs offspring's intestinal health and colitis susceptibility throughout life.
A common oat fiber supercharges anti-PD-1 checkpoint therapy by expanding a key gut microbe that produces immune-activating metabolites.
New research reveals how specific gut bacteria produce enzymes that can degrade the intestinal mucus layer that protects us from pathogens.
Researchers identify a gut-microbe-driven pathway linking IBS-D and insulin resistance, with oleoylethanolamide as a key therapeutic molecule.
Fecal microbiota transplants from healthy adult pigs protected newborn piglets from severe coronavirus diarrhea and death.
